These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27896760)

  • 21. Development and application of a novel Bio-Plex suspension array system for high-throughput multiplexed nucleic acid detection of seven respiratory and reproductive pathogens in swine.
    Xiao L; Wang Y; Kang R; Wu X; Lin H; Ye Y; Yu J; Ye J; Xie J; Cao Y; Wei Y; Liao D; Pan M; Lin Y; Dai Z; Li X
    J Virol Methods; 2018 Nov; 261():104-111. PubMed ID: 30145179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research progress of feature selection and machine learning methods for mass spectrometry-based protein biomarker discovery].
    Xu K; Han M; Huang C; Chang C; Zhu Y
    Sheng Wu Gong Cheng Xue Bao; 2019 Sep; 35(9):1619-1632. PubMed ID: 31559744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a bead-based multiplex assay for the simultaneous detection of porcine inflammation markers using xMAP technology.
    Bongoni AK; Lanz J; Rieben R; Banz Y
    Cytometry A; 2013 Jul; 83(7):636-47. PubMed ID: 23576245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplex Immunoassay Profiling.
    Stephen L
    Methods Mol Biol; 2017; 1546():169-176. PubMed ID: 27896766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The discovery and validation of colorectal cancer biomarkers.
    Ang CS; Phung J; Nice EC
    Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?
    Ansari D; Sambergs F; Johansson L; Andersson R
    Expert Rev Proteomics; 2017 Jun; 14(6):469-471. PubMed ID: 28388239
    [No Abstract]   [Full Text] [Related]  

  • 27. Machine Learning Techniques for High-Throughput Structure and Function Analysis for Proteomics and Genomics.
    Zou Q
    Comb Chem High Throughput Screen; 2019; 22(10):664. PubMed ID: 31984877
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiplex and accurate quantification of acute kidney injury biomarker candidates in urine using Protein Standard Absolute Quantification (PSAQ) and targeted proteomics.
    Gilquin B; Louwagie M; Jaquinod M; Cez A; Picard G; El Kholy L; Surin B; Garin J; Ferro M; Kofman T; Barau C; Plaisier E; Ronco P; Brun V
    Talanta; 2017 Mar; 164():77-84. PubMed ID: 28107998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.
    Jani D; Allinson J; Berisha F; Cowan KJ; Devanarayan V; Gleason C; Jeromin A; Keller S; Khan MU; Nowatzke B; Rhyne P; Stephen L
    AAPS J; 2016 Jan; 18(1):1-14. PubMed ID: 26377333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Algorithm development for diagnostic biomarker assays.
    Izmailov R; Guest PC; Bahn S; Schwarz E
    Int Rev Neurobiol; 2011; 101():279-98. PubMed ID: 22050856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selected reaction monitoring approach for validating peptide biomarkers.
    Wang Q; Zhang M; Tomita T; Vogelstein JT; Zhou S; Papadopoulos N; Kinzler KW; Vogelstein B
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13519-13524. PubMed ID: 29203663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteome signatures--how are they obtained and what do they teach us?
    da Costa JP; Carvalhais V; Ferreira R; Amado F; Vilanova M; Cerca N; Vitorino R
    Appl Microbiol Biotechnol; 2015 Sep; 99(18):7417-31. PubMed ID: 26205520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers for amyotrophic lateral sclerosis.
    Bowser R; Cudkowicz M; Kaddurah-Daouk R
    Expert Rev Mol Diagn; 2006 May; 6(3):387-98. PubMed ID: 16706741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical evaluation of FDA-approved respiratory multiplex assays for public health surveillance.
    Diaz-Decaro JD; Green NM; Godwin HA
    Expert Rev Mol Diagn; 2018 Jul; 18(7):631-643. PubMed ID: 29886764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diagnostics: hurdles for clinical implementation.
    Fortina P; Surrey S; Kricka LJ
    Trends Mol Med; 2002 Jun; 8(6):264-6. PubMed ID: 12067610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From bench to MS bedside: challenges translating biomarker discovery to clinical practice.
    Rajasekharan S; Bar-Or A;
    J Neuroimmunol; 2012 Jul; 248(1-2):66-72. PubMed ID: 22381245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical application of supersensitive and multiplex assay, MUSTag technology].
    Shibasaki F; Morizane Y; Ishikawa Y; Makisaka N; Komata Y; Chen L; Uchida K
    Rinsho Byori; 2008 Sep; 56(9):802-10. PubMed ID: 18975559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of machine learning for high-throughput tumor marker screening.
    Fu X; Ma W; Zuo Q; Qi Y; Zhang S; Zhao Y
    Life Sci; 2024 Jul; 348():122634. PubMed ID: 38685558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parallel and multiplexed bead-based assays and encoding strategies.
    Yingyongnarongkul BE; How SE; Díaz-Mochón JJ; Muzerelle M; Bradley M
    Comb Chem High Throughput Screen; 2003 Nov; 6(7):577-87. PubMed ID: 14683488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.